5FRANKLIN T J, MORRIS W P. Pharmacodynamics of the inhibition of GTP synthesis in vivo by mycophenolic acid [ J ]. Advances in Enzyme Regulation, 1994,34 : 107-117. 被引量：1
6SCHENA F P. Immunoglobulin A nephropathy with mild renal lesions: A call in the forest for physicians and nephrologists [J]. Am J Med, 2001,110:499-500. 被引量：1
7TANG S, LEUNG J C, CHAN L Y, et al. Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy[ J]. Kidney Int, 2005,68 (2) :802-812. 被引量：1
8FRISCH G, LIN J, ROSENSTOCK J, et al. Mycophenolate mofetil(MMF) vs placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trial [ J ]. Nephrol Dial Transplant,2005,20:2139-2145. 被引量：1
9MAES B D, OYEN R, CLAES K, et al. Mycophenolate mofetil in IgA nephropathy: results of a 3 year prospective placebo-controlled randomized study[ J]. Kidney Int, 2004, 65 : 1842-1849. 被引量：1
10TANG S, TANG A, WONG S, et al. Long-term study of mycophenolate mofetil treatment in IgA nephropathy [ J ]. Kidney International, 2010,77 : 543-549. 被引量：1
